Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
The U.S. Food & Drug Administration just approved Eli Lilly's GLP-1 pill orforglipron.
Source: www.fool.com
The U.S. Food & Drug Administration just approved Eli Lilly's GLP-1 pill orforglipron.